CN103153308A - Trpa1受体拮抗剂 - Google Patents
Trpa1受体拮抗剂 Download PDFInfo
- Publication number
- CN103153308A CN103153308A CN2011800494523A CN201180049452A CN103153308A CN 103153308 A CN103153308 A CN 103153308A CN 2011800494523 A CN2011800494523 A CN 2011800494523A CN 201180049452 A CN201180049452 A CN 201180049452A CN 103153308 A CN103153308 A CN 103153308A
- Authority
- CN
- China
- Prior art keywords
- pain
- compound
- relevant
- treatment
- maincenter
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- LSUGPAVXOXLORK-QFIPXVFZSA-N CC(C)(C)[C@H](C(c(cc1)ccc1C#N)=O)NC(N(CC1)CCN1c1nc(C)ccc1)=O Chemical compound CC(C)(C)[C@H](C(c(cc1)ccc1C#N)=O)NC(N(CC1)CCN1c1nc(C)ccc1)=O LSUGPAVXOXLORK-QFIPXVFZSA-N 0.000 description 1
- VOSMEFSBAHULFT-UHFFFAOYSA-N Cc1cccc(N2CCNCC2)n1 Chemical compound Cc1cccc(N2CCNCC2)n1 VOSMEFSBAHULFT-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Abstract
Description
Claims (10)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US39213010P | 2010-10-12 | 2010-10-12 | |
US61/392,130 | 2010-10-12 | ||
PCT/SE2011/051213 WO2012050512A1 (en) | 2010-10-12 | 2011-10-11 | Trpa1 receptor antagonist |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103153308A true CN103153308A (zh) | 2013-06-12 |
CN103153308B CN103153308B (zh) | 2015-06-03 |
Family
ID=45938532
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201180049452.3A Active CN103153308B (zh) | 2010-10-12 | 2011-10-11 | Trpa1受体拮抗剂 |
Country Status (5)
Country | Link |
---|---|
US (1) | US8859556B2 (zh) |
EP (1) | EP2627329B1 (zh) |
JP (1) | JP5847827B2 (zh) |
CN (1) | CN103153308B (zh) |
WO (1) | WO2012050512A1 (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103760286A (zh) * | 2014-01-14 | 2014-04-30 | 北京万全德众医药生物技术有限公司 | 一种用高效液相色谱法测定琥珀酸索非那新中间体光学纯度的方法 |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2742048B1 (en) | 2011-08-09 | 2016-04-27 | Hydra Biosciences, Inc. | Inhibiting transient receptor potential ion channel trpa1 |
EP2805718B1 (en) | 2012-01-17 | 2018-04-04 | EA Pharma Co., Ltd. | Heterocyclic amide derivative and pharmaceutical product containing same |
US9394308B2 (en) | 2013-01-18 | 2016-07-19 | Merck Sharp & Dohme Corp. | Inhibiting the transient receptor potential A1 ion channel |
WO2014184248A2 (en) * | 2013-05-15 | 2014-11-20 | Acturum Life Science AB | Trpa1 antagonist compounds |
WO2017060488A1 (en) | 2015-10-09 | 2017-04-13 | Almirall, S.A. | New trpa1 antagonists |
WO2017064068A1 (en) | 2015-10-14 | 2017-04-20 | Almirall, S.A. | New trpa1 antagonists |
IT202100015098A1 (it) * | 2021-06-09 | 2022-12-09 | Flonext S R L | Composto antagonista del canale trpa1 per uso in patologie degenerative della retina |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1832935A (zh) * | 2003-08-01 | 2006-09-13 | 欧洲凯尔特公司 | 用于治疗疼痛的治疗药 |
WO2008007103A1 (en) * | 2006-07-14 | 2008-01-17 | Amura Therapeutics Limited | Furo [3, 2-b] pyrrol derivatives |
WO2010075353A1 (en) * | 2008-12-22 | 2010-07-01 | Hydra Biosciences, Inc. | Compositions useful for treating disorders related to trpa1 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1770091A1 (de) * | 2005-09-29 | 2007-04-04 | Boehringer Ingelheim Pharma GmbH & Co. KG | CGRP-Antagonisten, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel |
TWI423819B (zh) | 2005-12-22 | 2014-01-21 | Hydra Biosciences Inc | 用於調節trpa1功能之化合物 |
US9108905B2 (en) | 2008-01-04 | 2015-08-18 | Abbvie Inc. | TRPA1 antagonists |
WO2010004390A1 (en) | 2008-06-17 | 2010-01-14 | Glenmark Pharmaceuticals, S.A. | Quinazoline dione derivatives as trpa1 modulators |
-
2011
- 2011-10-11 JP JP2013533819A patent/JP5847827B2/ja active Active
- 2011-10-11 CN CN201180049452.3A patent/CN103153308B/zh active Active
- 2011-10-11 WO PCT/SE2011/051213 patent/WO2012050512A1/en active Application Filing
- 2011-10-11 US US13/878,862 patent/US8859556B2/en active Active
- 2011-10-11 EP EP11832839.2A patent/EP2627329B1/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1832935A (zh) * | 2003-08-01 | 2006-09-13 | 欧洲凯尔特公司 | 用于治疗疼痛的治疗药 |
WO2008007103A1 (en) * | 2006-07-14 | 2008-01-17 | Amura Therapeutics Limited | Furo [3, 2-b] pyrrol derivatives |
WO2010075353A1 (en) * | 2008-12-22 | 2010-07-01 | Hydra Biosciences, Inc. | Compositions useful for treating disorders related to trpa1 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103760286A (zh) * | 2014-01-14 | 2014-04-30 | 北京万全德众医药生物技术有限公司 | 一种用高效液相色谱法测定琥珀酸索非那新中间体光学纯度的方法 |
Also Published As
Publication number | Publication date |
---|---|
EP2627329B1 (en) | 2015-07-08 |
EP2627329A1 (en) | 2013-08-21 |
US20140148466A1 (en) | 2014-05-29 |
EP2627329A4 (en) | 2014-03-05 |
US8859556B2 (en) | 2014-10-14 |
JP5847827B2 (ja) | 2016-01-27 |
JP2013539781A (ja) | 2013-10-28 |
CN103153308B (zh) | 2015-06-03 |
WO2012050512A1 (en) | 2012-04-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103153308B (zh) | Trpa1受体拮抗剂 | |
US9187474B2 (en) | Raf inhibitor compounds | |
KR102455519B1 (ko) | ROS1 저해제로서의 치환된 4,5,6,7-테트라히드로피라졸로[1,5-a]피라진 유도체 및 5,6,7,8-테트라히드로-4H-피라졸로[1,5-a][1,4]디아제핀 유도체 | |
WO2017101803A1 (zh) | 一种新型egfr和alk激酶的双重抑制剂 | |
JP3993651B2 (ja) | シクロプロパクロメンカルボン酸誘導体 | |
CN105682661A (zh) | 某些化学实体、组合物和方法 | |
WO2001087834A1 (fr) | Antagoniste de l'hormone de concentration de la melanine | |
JP2009040778A (ja) | ムスカリン様アンタゴニスト | |
MX2015003637A (es) | Piridinonas biciclicas novedosas. | |
CA3153529A1 (en) | Brd9 bifunctional degraders and their methods of use | |
EA007225B1 (ru) | Производные n-[фенил(пиперидин-2-ил)метил]бензамида и их применение в терапии | |
JP2017508779A5 (zh) | ||
CN100516040C (zh) | 具有2,6-二取代苯乙烯基的含氮杂环衍生物 | |
CN103608343A (zh) | 用于制备作为***素受体调节剂的稠合氮杂环的晶形和制备方法 | |
TWI520945B (zh) | 環丙基苯甲醯胺衍生物之新穎結晶形式 | |
AU2020408107A1 (en) | Compounds active towards nuclear receptors | |
CN114773318A (zh) | 含有六元氮杂杂环的δ阿片受体调节化合物、其使用和制备方法 | |
JPWO2020017587A1 (ja) | ピリダジノン誘導体 | |
TW438746B (en) | New phenylamidine derivatives, processes for preparing them and their use as pharmaceutical compositions | |
CN103180312A (zh) | 用于治疗或预防因血清素、去甲肾上腺素或多巴胺的神经传导的降低所导致的紊乱的杂环化合物 | |
JP5486008B2 (ja) | 1‐ブチル‐2‐ヒドロキシアラルキルピペラジン誘導体およびその抗鬱剤としての使用 | |
CA2690789C (en) | 4-phenylpiperazine derivatives with functionalized linkers as dopamine d3 receptor selective ligands and methods of use | |
CN102617478B (zh) | 苯并咪唑、噁唑和噻唑衍生物的合成及其应用 | |
CN103204816B (zh) | 哌嗪基嘧啶类衍生物及其制备方法和用途 | |
JP2001520224A (ja) | 2−置換1,2−ベンジイソチアゾール誘導体およびそのセロトニン拮抗薬(5−ht1a、5−ht1b、5−ht1d)としての使用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: AKETURAM LIFE SCIENCES AG Free format text: FORMER OWNER: ASTRAZENECA AB Effective date: 20141209 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20141209 Address after: Solna, Sweden Applicant after: ACTURUM LIFE SCIENCE AB Address before: Swedish Sodertalje Applicant before: ASTRAZENECA AB |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20190821 Address after: Solna, Sweden Patentee after: Akturam Life Co.,Ltd. Address before: Solna, Sweden Patentee before: Akturam Real Estate Co.,Ltd. Effective date of registration: 20190821 Address after: Solna, Sweden Patentee after: Akturam Real Estate Co.,Ltd. Address before: Solna, Sweden Patentee before: ACTURUM LIFE SCIENCE AB |
|
TR01 | Transfer of patent right |